Wheeler DL - Search Results

1

AXL mediates resistance to cetuximab therapy.

Brand TM, Iida M, Stein AP, Corrigan KL, Braverman CM, Luthar N, Toulany M, Gill PS, Salgia R, Kimple RJ, Wheeler DL. Brand TM, et al. Among authors: wheeler dl. Cancer Res. 2014 Sep 15;74(18):5152-64. doi: 10.1158/0008-5472.CAN-14-0294. Epub 2014 Aug 18. Cancer Res. 2014. PMID: 25136066 Free PMC article.

2

Protein kinase C-epsilon transgenic mice: a unique model for metastatic squamous cell carcinoma.

Jansen AP, Verwiebe EG, Dreckschmidt NE, Wheeler DL, Oberley TD, Verma AK. Jansen AP, et al. Among authors: wheeler dl. Cancer Res. 2001 Feb 1;61(3):808-12. Cancer Res. 2001. PMID: 11221859

3

Inhibition of the development of metastatic squamous cell carcinoma in protein kinase C epsilon transgenic mice by alpha-difluoromethylornithine accompanied by marked hair follicle degeneration and hair loss.

Wheeler DL, Ness KJ, Oberley TD, Verma AK. Wheeler DL, et al. Cancer Res. 2003 Jun 15;63(12):3037-42. Cancer Res. 2003. PMID: 12810623

4

Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice.

Wheeler DL, Ness KJ, Oberley TD, Verma AK. Wheeler DL, et al. Cancer Res. 2003 Oct 1;63(19):6547-55. Cancer Res. 2003. PMID: 14559850

5

Protein kinase C epsilon is an endogenous photosensitizer that enhances ultraviolet radiation-induced cutaneous damage and development of squamous cell carcinomas.

Wheeler DL, Martin KE, Ness KJ, Li Y, Dreckschmidt NE, Wartman M, Ananthaswamy HN, Mitchell DL, Verma AK. Wheeler DL, et al. Cancer Res. 2004 Nov 1;64(21):7756-65. doi: 10.1158/0008-5472.CAN-04-1881. Cancer Res. 2004. PMID: 15520180

6

Protein kinase C delta overexpressing transgenic mice are resistant to chemically but not to UV radiation-induced development of squamous cell carcinomas: a possible link to specific cytokines and cyclooxygenase-2.

Aziz MH, Wheeler DL, Bhamb B, Verma AK. Aziz MH, et al. Among authors: wheeler dl. Cancer Res. 2006 Jan 15;66(2):713-22. doi: 10.1158/0008-5472.CAN-05-2684. Cancer Res. 2006. PMID: 16424000

7

Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members.

Wheeler DL, Huang S, Kruser TJ, Nechrebecki MM, Armstrong EA, Benavente S, Gondi V, Hsu KT, Harari PM. Wheeler DL, et al. Oncogene. 2008 Jun 26;27(28):3944-56. doi: 10.1038/onc.2008.19. Epub 2008 Feb 25. Oncogene. 2008. PMID: 18297114 Free PMC article.

8

ErbB4 targeting approaches for prostate cancer treatment.

Wheeler DL, Rangnekar VM, Schwarze SR. Wheeler DL, et al. Cancer Biol Ther. 2008 Jul;7(7):1095-7. doi: 10.4161/cbt.7.7.6537. Epub 2008 Jun 30. Cancer Biol Ther. 2008. PMID: 18698169 Free article. No abstract available.

9

Augmentation of radiation response by panitumumab in models of upper aerodigestive tract cancer.

Kruser TJ, Armstrong EA, Ghia AJ, Huang S, Wheeler DL, Radinsky R, Freeman DJ, Harari PM. Kruser TJ, et al. Among authors: wheeler dl. Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):534-42. doi: 10.1016/j.ijrobp.2008.06.1490. Int J Radiat Oncol Biol Phys. 2008. PMID: 18793955 Free PMC article.

10

Establishment and characterization of a model of acquired resistance to epidermal growth factor receptor targeting agents in human cancer cells.

Benavente S, Huang S, Armstrong EA, Chi A, Hsu KT, Wheeler DL, Harari PM. Benavente S, et al. Among authors: wheeler dl. Clin Cancer Res. 2009 Mar 1;15(5):1585-92. doi: 10.1158/1078-0432.CCR-08-2068. Epub 2009 Feb 3. Clin Cancer Res. 2009. PMID: 19190133 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters